UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Cervical cancer treatment evolves with molecular screening and immunotherapies, emphasizing early detection as key to ...

Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.

Cipla, a global pharmaceutical leader, has partnered with ImmunoACT to introduce talicabtagene autoleucel in Africa. This is ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Researchers analyzed the health records of more than 33,800 U.S. veterans diagnosed with non-melanoma skin cancer and found ...

Amid growing evidence suggesting circadian rhythms play a critical in the safety and efficacy of CAR T-cell therapy, ...

United StatesAurum Capital has launched its Investment-Driven Medical Innovation Initiative, aiming to expand research ...

A new partnership between The Ottawa Hospital and the University of Ottawa will help make Canada more self-reliant in the ...

Blood transfusions are essential for patients with cancer, sickle cell disease, and traumatic injuries, but blood supply ...

At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

January is a crucial time for blood donations, especially after a decline during the holiday season and the effects of cold ...